SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-18-012305
Filing Date
2018-09-10
Accepted
2018-09-07 21:53:39
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b3090718_adialpharma.htm 424B3 943343
2 GRAPHIC logo_001.jpg GRAPHIC 21201
3 GRAPHIC img_001.jpg GRAPHIC 21663
  Complete submission text file 0001213900-18-012305.txt   1003858
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22902 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-220368 | Film No.: 181061319
SIC: 2834 Pharmaceutical Preparations